Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients

被引：7
|
作者：
Berruti, Alfredo [1 ]
Tucci, Marcello
Mosca, Alessandra
Vana, Federica
Ardine, Mara
Dogliotti, Luigi
Angeli, Alberto
Bertoldo, Francesco
机构：
[1] Univ Turin, Oncol Med Azienda Osped San Luigi, Dipartimento Sci Clin & Biol, Orbassano, Italy
[2] Azienda Sanitaria Locale 8, Chiezi, Italy
[3] Univ Verona, Policlin GB Rossi, Dipartimento Sci Biomed & Chirurg, Sez Med D, I-37100 Verona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 11期
关键词：
D O I：
10.1200/JCO.2006.08.7080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1455 / 1456
页数：3
相关论文
共 50 条
  • [11] Effect of Aromatase Inhibitors on Bone Mineral Density in a Japanese Breast Cancer Population
    Akiyoshi, Takeshi
    Shimomura, Yuka
    Masuda, Shinichi
    Okamoto, Yasushi
    Hiura, Sumiko
    Kato, Hiroyoshi
    Asayama, Toru
    Ohtani, Hisakazu
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (05) : 446 - 450
  • [12] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Markopoulos, Christos
    BREAST CANCER RESEARCH, 2010, 12 (04)
  • [13] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Christos Markopoulos
    Breast Cancer Research, 12
  • [14] Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
    Sakaguchi, Koichi
    Ono, Hisako
    Nakatsukasa, Katsuhiko
    Ishikawa, Takashi
    Hasegawa, Yoshie
    Takahashi, Masato
    Niikura, Naoki
    Koizumi, Kei
    Sakurai, Teruhisa
    Shigematsu, Hideo
    Takahashi, Shunji
    Taira, Shinichiro
    Suzuki, Masato
    Narui, Kazutaka
    Miura, Daishu
    Yamada, Kimito
    Yoshimura, Mana
    Shioya, Hisashi
    Konishi, Eiichi
    Isao, Yokota
    Imai, Kojiro
    Fujikawa, Kei
    Taguchi, Tetsuya
    MEDICINE, 2019, 98 (32)
  • [15] Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs).
    Charlson, John A.
    Smith, Elizabeth
    Laud, Purushottam
    Smallwood, Alicia
    Neuner, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [16] Aromatase inhibitors as adjuvant therapies in patients with breast cancer
    Coombes, RC
    Gibson, L
    Hall, E
    Emson, M
    Bliss, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 309 - 311
  • [17] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Masahiro Shibata
    Mai Okumura
    Shin Kawano
    Hirotoshi Noda
    Chihiro Toyota
    Yutaka Mizuno
    Journal of Bone and Mineral Metabolism, 2023, 41 : 567 - 574
  • [18] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Tsaaareli, M.
    Giorgadze, E.
    Khachidze, N.
    Sharilcadze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S268 - S269
  • [19] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Shibata, Masahiro
    Okumura, Mai
    Kawano, Shin
    Noda, Hirotoshi
    Toyota, Chihiro
    Mizuno, Yutaka
    JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (04) : 567 - 574
  • [20] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
12345